Polymorphisms in the promoter region of the basic fibroblast growth factor gene and proliferative diabetic retinopathy in Caucasians with type 2 diabetes

Clinical and Experimental Ophthalmology

Volumn 36, Issue 2, 2008, Pages 168-172

  Petrovič, Mojca Globočnik ^a   Krkovič, Miha ^b   Osredkar, Joško ^a   Hawlina, Marko ^a   Petrovič, Daniel ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

553T A; 834T Aand 921C G gene polymorphisms; Association study; Basic fibroblast growth factor gene; Genetic risk factors; Proliferative diabetic retinopathy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INSULIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; PROTEIN BLOOD LEVEL; SLOVENIA;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; SLOVENIA;

EID: 41249088219     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01647.x     Document Type: Article

References (24)

1. Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-7.
2. Adamis AP, Miller JW, Bernal MT et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118: 445-50.
3. Funatsu H, Yamashita H, Nakanishi Y, Hori S. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophthalmol 2002; 86: 311-5.
4. Petrovic MG, Korosec P, Kosnik M, Hawlina M. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2007; 143: 175-6.
5. Song E, Dong Y, Han LN et al. Diabetic retinopathy: VEGF, bFGF and retinal vascular pathology. Chin Med J (Engl) 2004; 117: 247-51.
6. Watanabe D, Suzuma K, Suzuma I et al. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2005; 139: 476-81.
7. Yang HT, Yan Z, Abraham JA, Terjung RL. VEGF121- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol 2001; 280: H1097-H1104.
8. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 26-45.
9. Teshima-Kondo S, Kondo K et al. Hyperglycemia upregulates translation of the fibroblast growth factor 2 mRNA in mouse aorta via internal ribosome entry site. FASEB J 2004; 18: 1583-5.
10. Iwai-Kanai E, Hasegawa K, Fujita M et al. Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 2002; 190: 54-62.
11. Hueber A, Wiedemann P, Esser P, Heimann K. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Int Ophthalmol 1996-97; 20: 345-50.
12. Awata T, Inoue K, Kurihara S et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51: 1635-9.
13. Peterlin B, Globocnik Petrovic M, Makuc J, Hawlina M, Petrovic D. A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes. J Hum Genet 2003; 48: 646-9.
14. Uhlmann K, Kovacs P, Boettcher Y, Hammes HP, Paschke R. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2006; 114: 275-94.
15. Beranek M, Tschoplova S, Kankova K, Kuhrova V, Vacha J. Genetic variation in the promoter region of the basic fibroblast growth factor gene. Hum Immunol 2003; 64: 374-7.
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl. 1): S5-S20.
17. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification ETDRS report number 10. Ophthalmology 1991; 98 (Suppl. 5): 786-806.
18. Sivalingam AKJ, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990; 108: 869-72.
19. Karpen CW, Spanheimer RG, Randolph AL, Lowe WL. Tissue-specific regulation of basic fibroblast growth factor mRNA levels by diabetes. Diabetes 1992; 41: 222-6.
20. Zimering MB, Eng J. Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. J Clin Endocrinol Metab 1996; 81: 4446-52.
21. Hill DJ, Flyvbjerg A, Arany E, Lauszus FF, Klebe JG. Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy. J Clin Endocrinol Metab 1997; 82: 1452-7.
22. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 8150-4.
23. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: The Oslo study. Br Med J (Clin Res Ed) 1985; 290: 811-5.
24. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: Scientific review. JAMA 2003; 289: 2254-64.